Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
Entera Bio Ltd. (ENTX) reported a Q3 loss of $0.08 per share, which was wider than the Zacks Consensus Estimate of a $0.05 loss. However, the company exceeded revenue expectations.
November 08, 2024 | 11:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Entera Bio Ltd. reported a Q3 loss of $0.08 per share, missing the Zacks Consensus Estimate of a $0.05 loss. Despite this, the company exceeded revenue expectations.
The reported loss per share was greater than expected, which is typically negative for stock prices. However, exceeding revenue expectations could mitigate some negative impact. Overall, the missed earnings estimate is likely to have a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100